Mode
Text Size
Log in / Sign up
N/A N=672 Diagnostic

Assessment of InfraScanner 2000™ in Detecting Subdural and Epidural Hematomas

Head Trauma · Craniocerebral Injuries · Crushing Skull Injury · Head Injuries · Head Injuries, Multiple

Enrolled (actual)
672
Serious AEs
Results posted
Mar 2024
Primary outcome: Primary: Number of Participants With Detection of Hematoma Stratified by CT Positive and CT Negative Status — 158; 22; 126; 81 Participants

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
InfraScanner 2000™ (Device)
Age
Pediatric, Adult, Older Adult
Sex
All
Sponsor
Duke University
Primary completion
Jun 2022

Outcome Measures

OutcomeResultp-value
PRIMARY
Number of Participants With Detection of Hematoma Stratified by CT Positive and CT Negative Status
158; 22; 126; 81
SECONDARY
Number of Participants With Detection of Hematoma Stratified by CT Positive and CT Negative Status (Adjusted for Volume and Size of Hematoma)
136; 15; 126; 81
SECONDARY
Number of Participants With Detection of Hematoma Stratified by CT Positive and CT Negative Status (Adjusted for Depth of Hematoma)
148; 17; 126; 81
SECONDARY
Clinical Patient Outcomes as Measured by the Glasgow Outcomes Scale (GOSE)
47; 252; 41; 9; 2; 0
SECONDARY
Identify Reasons CT Not Performed
SECONDARY
Causes of Head Trauma as Identified Through the Medical Record
179; 36; 24; 14; 12; 9

Summary

The goal of this study is to determine the sensitivity, specificity, and positive and negative predictive values of the a portable near-infrared-based device (portable NIR-based device), the InfraScanner 2000™, to detect intracranial hematomas (epidural hematomas (EDH) and/or subdural hematomas (SDH)) in patients hospitalized at Mbarara Regional Referral Hospital (MRRH) who have sustained or who are suspected to have sustained head trauma.

Eligibility Criteria

Inclusion Criteria

  • Any patient who presents to MRRH with suspected head trauma, who is able to or who has a legally authorized representative who is able consent in English, Swahili, or Luganda will be considered for this study.

Exclusion Criteria

  • None
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04505293). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search